Cancer Screening

Our proprietary miRNA technology detects cancer at its earliest, most treatable stages. With minimally invasive test and accurate insights, our tests enable patients to act sooner.

A pioneering blood test for the early detection of gastric (stomach) cancer.

LUNGClear

A minimally invasive blood test designed to identify lung cancer at an early stage.

Cancer Treatment Selection

We leverage advanced Next-Generation Sequencing (NGS) technology to empower patients in personalised cancer treatment selection.

APEX Tissue

A Targeted 58-Gene Profiling Test

COMPASS Tissue

A Comprehensive 1021-Gene Profiling Test

AI In Precision Medicine

From ML to AI, Embracing Their Full Potential Decisively

The Future We’re Acting On

At Mirxes, Artificial Intelligence (AI) is not a new concept; it has long been at the heart of our laboratory operations. We have consistently leveraged Machine Learning (ML) to extract critical insights from complex data, incorporating them into the iterative design of our studies and assays. However, we recognize that AI is evolving rapidly and represents far more than ML.

Our corporate tagline, “To Know. To Act.” is more than a call to the public — it is the standard we live by. Having recognized AI as the cornerstone of the future (“Know”), we are moving decisively to embrace its full potential (“Act”). By fusing our expertise in multi-cancer early detection with the transformative power of AI, we are redefining the precision health landscape for everyone.

Our AI Strategy: A Clear Path Forward

Strategy Pillar

We aren't just using AI for the sake of it. Our strategy is built on four core pillars designed to deliver real-world impact.

Curated Data

We utilize well-curated, Asian-centric datasets to ensure our AI is accurate and relevant to the communities we focus on.

Product Integration

We are embedding AI directly into selected testing products to provide more comprehensive and actionable health insights.

Operational Excellence

By automating complex laboratory processes, we can deliver faster results and maintain the highest quality standards.

Value & Accessibility

Our goal is to use AI to reduce costs and create efficient platforms, making life-saving early detection more accessible.

How We Are Bringing AI to Life

First

Second

Third

Fourth

We are integrating AI across our entire workflow to enhance how we detect and understand disease

Smarter Detection (CADENCE AI):
We use advanced algorithms to analyze DNA methylation and fragmentation patterns, helping us find the earliest signs of cancer with greater precision.
Precision Reports:
Our AI-driven oncology reports help doctors interpret complex genomic findings quickly, leading to better-informed treatment plans.
Faster Innovation:
By automating bioinformatics pipelines, our scientists can spend more time discovering new ways to save lives and less time on manual data entry.
Personalized Support:
We are developing AI-powered tools and programmes, like product chatbots and internal training modules, to provide clearer information and support to our partners, customers and staff.

Build the Foundation Together

To ensure we use AI responsibly and effectively, we have established an AI Centre of Excellence (AI-COE). This team brings together experts in (1) Bioinformatics, (2) Clinical Research, (3) IT and Infrastructure and (4) Quality Assurance. Through partnerships with global leaders like Google Cloud, Kyndryl and Oracle, we are building a world-class infrastructure that ensures your data is handled with the utmist security and care.

Engineering Intelligence with Purpose

The AI-COE operates as a centralized engine for innovation, bridging the gap between cutting-edge technology and clinical application. By standardizing protocols and fostering cross-functional collaboration, the centre ensures that every AI model developed is rigously validated for accuracy, ethical compliance and scalability. This coallborative framework allows us to rapidly prototype new solutions while maintaining a singular focus on delivering reliable, life-saving insights through a harmonized digital ecosystem.

Protecting What Matters Most

At the heart of our data strategy is a strong commitment to the Personal Data Protection Act (PDPA). We recognise our responsibility to safeguard sensitive health information and treat data privacy as a core organisational priority. Our AI Centre of Excellence applies Privacy by Design principles, ensuring that personal data is handled in accordance with applicable consent, notification and purpose limitation requirements and protected by appropriate technical and organisational safeguards. We regularly review our practices to support responsible AI innovation while maintaining trust and protecting individuals’ privacy.